News

Clinical Trials Arena1h
NewAmsterdam reports prespecified Alzheimer’s biomarker data in Phase III trial
NewAmsterdam Pharma has reported encouraging topline data from a prespecified biomarker analysis of Alzheimer’s disease in a ...
Clinical Trials Arena2h
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer
Daiichi Sankyo has announced the first subject dosing in the Phase III DESTINYEndometrial01 trial of Enhertu (trastuzumab ...
Clinical Trials Arena4h
Regeneron and Sanofi’s dupilumab shows promise in AD trial
Regeneron and Sanofi have announced promising outcomes from the open-label Phase IV DISCOVER trial of Dupixent (dupilumab).